SBC Medical Group Holdings, Inc.

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: US73245B1070
USD
4.52
0.14 (3.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Is SBC Medical Group Holdings, Inc. overvalued or undervalued?

20-Sep-2025

As of August 13, 2025, SBC Medical Group Holdings, Inc. has shifted from a fair to an attractive valuation grade, appearing undervalued with a P/E ratio of 11.684 and favorable comparisons to industry peers, despite a year-to-date return of -16.37%, while recently outperforming the S&P 500 over the past week and month.

As of 13 August 2025, the valuation grade for SBC Medical Group Holdings, Inc. moved from fair to attractive, indicating a positive shift in its perceived value. The company appears undervalued based on its current metrics, with a P/E ratio of 11.684, an EV to EBITDA ratio of 4.9677, and a price to book value that suggests a favorable comparison to its peers. <BR><BR>In comparison to its industry, SBC Medical Group Holdings, Inc. is positioned favorably against competitors such as the average industry P/E, which typically reflects higher valuations. Notably, while the company has experienced a year-to-date return of -16.37%, it has outperformed the S&P 500 over the past week and month, with returns of 3.56% and 9.67%, respectively, suggesting a potential rebound in investor sentiment.

Read More

Is SBC Medical Group Holdings, Inc. technically bullish or bearish?

20-Sep-2025

As of October 1, 2023, SBC Medical Group Holdings, Inc. shows a mixed technical trend with a mildly bullish weekly outlook but bearish monthly indicators, having outperformed the S&P 500 in the short term while significantly underperforming year-to-date and over the past year.

As of 1 October 2023, the technical trend for SBC Medical Group Holdings, Inc. is mixed, with a mildly bullish stance on the weekly MACD and KST, while the monthly indicators show bearish signals. The Bollinger Bands are bullish weekly but mildly bearish monthly, and the daily moving averages indicate a mildly bearish trend. Overall, the stock is currently in a bearish to neutral position, with strength primarily derived from the weekly MACD and KST.<BR><BR>In terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 3.56% and 9.67% respectively, compared to the S&P 500's returns of 1.05% and 2.33%. However, the year-to-date and one-year returns are significantly negative at -16.37% and -39.3%, underperforming the S&P 500's positive returns of 12.22% and 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Negative results in Jun 25

  • INTEREST(9M) At USD 0.07 MM has Grown at inf%
  • NET PROFIT(Q) At USD 2.44 MM has Fallen at -76.36%
  • RAW MATERIAL COST(Y) Grown by 7.73% (YoY)
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 514 Million (Micro Cap)

stock-summary
P/E

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.57

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

2.10

Revenue and Profits:
Net Sales:
43 Million
(Quarterly Results - Jun 2025)
Net Profit:
2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.91%
0%
3.91%
6 Months
-2.8%
0%
-2.8%
1 Year
-28.25%
0%
-28.25%
2 Years
-58.19%
0%
-58.19%
3 Years
-55.42%
0%
-55.42%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

SBC Medical Group Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1,336.70%
EBIT Growth (5y)
832.20%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
EV to EBIT
EV to EBITDA
EV to Capital Employed
EV to Sales
PEG Ratio
NA
Dividend Yield
ROCE (Latest)
ROE (Latest)
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -8.25% vs 6.53% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -88.84% vs 230.77% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "43.40",
          "val2": "47.30",
          "chgp": "-8.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.20",
          "val2": "24.80",
          "chgp": "-38.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "8.70",
          "chgp": "-98.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.40",
          "val2": "21.50",
          "chgp": "-88.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "335.70%",
          "val2": "511.40%",
          "chgp": "-17.57%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.15% vs 0.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 20.98% vs 6,333.33% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "205.40",
          "val2": "193.50",
          "chgp": "6.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "89.20",
          "val2": "83.30",
          "chgp": "7.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-18.20",
          "val2": "-0.60",
          "chgp": "-2,933.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "46.70",
          "val2": "38.60",
          "chgp": "20.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "415.60%",
          "val2": "367.20%",
          "chgp": "4.84%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
43.40
47.30
-8.25%
Operating Profit (PBDIT) excl Other Income
15.20
24.80
-38.71%
Interest
0.00
0.00
Exceptional Items
0.10
8.70
-98.85%
Consolidate Net Profit
2.40
21.50
-88.84%
Operating Profit Margin (Excl OI)
335.70%
511.40%
-17.57%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -8.25% vs 6.53% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -88.84% vs 230.77% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
205.40
193.50
6.15%
Operating Profit (PBDIT) excl Other Income
89.20
83.30
7.08%
Interest
0.00
0.00
Exceptional Items
-18.20
-0.60
-2,933.33%
Consolidate Net Profit
46.70
38.60
20.98%
Operating Profit Margin (Excl OI)
415.60%
367.20%
4.84%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 6.15% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 20.98% vs 6,333.33% in Dec 2023

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details